A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR)
Not Applicable
Completed
- Conditions
- Emphysema
- Interventions
- Device: Chartis SystemDevice: Endobronchial Valve (EBV) Treatment
- First Posted Date
- 2010-04-12
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- Pulmonx Corporation
- Target Recruit Count
- 96
- Registration Number
- NCT01101958
- Locations
- 🇩🇪
University of Heidelberg, Heidelberg, Germany
🇳🇱UMC Groningen, Groningen, Netherlands
Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)
Phase 1
Completed
- Conditions
- Heterogeneous Emphysema
- Interventions
- Device: Chartis System
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2009-01-22
- Lead Sponsor
- Pulmonx Corporation
- Target Recruit Count
- 25
- Registration Number
- NCT00684892
- Locations
- 🇩🇪
Thoraxklinik am Universitatsklinikum Heidelberg, Heidelberg, Germany
Safety and Feasibility Study of the Chartis System
Phase 1
Completed
- Conditions
- Bronchoscopy
- Interventions
- Device: Chartis System
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2009-01-22
- Lead Sponsor
- Pulmonx Corporation
- Target Recruit Count
- 18
- Registration Number
- NCT00684684
- Locations
- 🇩🇪
Thoraxklinik am Universitatsklinikum Heidelberg, Heidelberg, Germany
© Copyright 2025. All Rights Reserved by MedPath